Clinical trial
Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction
NCT03229408 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 5, 2018
- Completion date
- February 28, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.